FDA
-
-
-
-
-
-
-
Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human Services (HTBX)
-
-
-
-
-
-
-
Heat Biologics Provides Third Quarter 2021 Business Update
-
-
-
-
-
-
-
After-Hours Stock Movers 03/02: (HTBX) (MRVI) (AMBA) Higher; (ARNA) (BGS) (MGY) Lower (more...)
-
-
-
-
-
-
-
Heat Biologics Announces First Patient Treated in First-in-Human Clinical Trial of PTX-35
-
-
-
-
-
-
-
Heat Biologics Presents Positive Survival Benefit for HS-110 in Combination with Nivolumab in Phase 2 Lung Cancer Trial at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting
-
-
-
-
-
-
-
Heat Biologics’ Pelican Subsidiary Provides Update on its Novel PTX-35 T-Cell Costimulator
-
-
-
-
-
-
-
Pre-Open Stock Movers 11/17: (HIBB) (TYME) (ANF) (SPLK) Higher; (VBLT) (CNTY) (VERI) Lower (more...)
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

